News About: Pharm. Industry
Mixed fortunes for foreign-invested pharmaceutical firms in Korea
For the immediate future, foreign-invested pharmaceutical firms expect positive growth in Korea's overall pharmaceutical markers, thanks to substantial accumulation of retained earnings for the past years, but...
Supreme Court reaffirms composition approval over Chosun Pharm
The Supreme Court rejected on March 16 the immediate appeal filed by Shin-A Trading against the composition of Chosun Pharm, which was supported by a lower court earlier.
In its ruling, the Supreme Court noted that...
Chong Kun Dang Bio ranks 72nd in leading 100 small- and medium-sized firms
Chong Kun Dang Bio placed 72nd rank in the local 100 small- and medium-sized businesses (SMBs) in terms of export records, according to recent data released by the Small and Medium Business Administration.
Led by m...
Dong-A to accept credit card payment for Bacchus F business.
In replying letter to the KPA over "Credit Card Payment for Bacchus F", Dong-A (President: Kang Moon-seok) officially make it clear that they would accept the credit card payment.
In the letter Dong-A said "We are...
Trademark dispute over Mendamneo terminated
Boryung Pharm says that the trademark dispute touched off by U.S.-based Mentholatum Co. two years ago against over its own brand Mendamneo was substantially terminated.
Mentholatum Co. brought a complaint at the en...
Dendritic cells-based immunotherapy to be commercialized next year
Keunwha Pharm said recently that its dendritic cells-based immunotherapy, which was developed in collaboration with Binex and research team of Pusan University last November, is to be launched next year after completi...
Lilly Korea teams up with Zuellig Korea
Lilly Korea, Korean unit of U.S.-based multinational pharmaceutical firm, said that beginning in April 1st, Zuellig Korea will be responsible for drug logistics business of Lilly Korea in the domestic hospital and pha...
Domestic Uwhangchungsimwon market heats upLocal competition of Uwhangchungsimwon (herbal medicine) market valued at 40.0 billion won is expected to be intensifying, as Borung Pharm, a leading herbal maker of Yongkaksan ...
|
Dongwha Pharm wins China patent for novel quinolone agent
Dongwha Pharm announced it has won China patent related to an optically active 7-pyrrolidine quinoline carboxylic acid derivative and its manufacturing method.
Dongwha officials said that the company invested two ...
Jecheon city intensifies efforts to lure pharmaceutical firms
With construction of Jecheon Biovalley Industrial Complex to be completed in coming June with investment of 23.5 billion won, the regional government of Chungcheong Province has begun enticing more companies involved ...
